Rituximab and Liposomal Doxorubicin Improve Progression-Free and Overall ... Monthly Prescribing Reference SAN DIEGO, CA—At the 53rd American Society of Hematology Annual Meeting and Exposition, study investigators presented evidence demonstrating promising survival rates in Burkitt's lymphoma (BL) when rituximab was added to the CODOX-M and IVAC ... |
